Wang Xin, Zhang Lei, Lu Hui, Wu Juan-Li, Liang Hua-Zheng, Liu Chong, Tao Qing-Qing, Wu Zhi-Ying, Zhu Ke-Qing
China Brain Bank and Department of Neurology in Second Affiliated Hospital, Key Laboratory of Medical Neurobiology of Zhejiang Province, and Department of Neurobiology, School of Medicine, Zhejiang University, Hangzhou 310058, China.
Department of Pathology, School of Medicine, Zhejiang University, Hangzhou 310058, China.
J Zhejiang Univ Sci B. 2020;21(3):256-262. doi: 10.1631/jzus.B1900262.
Primary age-related tauopathy (PART) is characterized by the presence of tau neurofibrillary tangles (NFTs) which are typically observed in Alzheimer's disease (AD) brains, with few or without β-amyloid (Aβ) plaques. The diagnosis of PART can be categorized into "definite" or "possible" depending on the amount of Aβ plaques. Definite PART is diagnosed when NFTs are observed and the Braak stage is ≤IV, with Thal Aβ Phase 0 (Crary et al., 2014). According to the neuropathological diagnostic criteria, we reported that PART was frequently observed in the Chinese population according to our findings from specimens in our brain bank, with 47% of brain bank subjects meeting the criteria for PART. There is no consensus on the nature of PART. It remains to be elucidated whether PART is an early form of AD or a novel tauopathy (Duyckaerts et al., 2015; Jellinger et al., 2015).
原发性年龄相关性tau蛋白病(PART)的特征是存在tau神经原纤维缠结(NFTs),这在阿尔茨海默病(AD)脑内通常可以观察到,而β-淀粉样蛋白(Aβ)斑块很少或没有。PART的诊断可根据Aβ斑块的数量分为“确诊”或“可能”。当观察到NFTs且Braak分期≤IV期,Thal Aβ分期为0期时,可诊断为确诊PART(Crary等人,2014年)。根据神经病理学诊断标准,根据我们脑库标本的研究结果,我们报告在中国人群中经常观察到PART,脑库中47%的受试者符合PART标准。关于PART的性质尚无共识。PART是AD的早期形式还是一种新型tau蛋白病仍有待阐明(Duyckaerts等人,2015年;Jellinger等人,2015年)。